Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2009

01.07.2009 | Case Report

Secondary involvement of the breast in T-cell non-Hodgkin lymphoma, an unusual example mimicking inflammatory breast carcinoma

verfasst von: Canan Kelten, Sibel Kabukcu, Nilay Sen, Zafer Teke, Arzu Yaren, Ergun Erdem, Ender Duzcan

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Non-Hodgkin lymphoma of the breast is a rare malignancy and present with almost equal frequency either as a primary or a secondary disease. Survival is poor in most cases of secondary breast lymphoma because of their advanced stage. We report a 35-year-old woman presenting with dyspnea as well as swelling, tenderness, and ruddiness in the left breast with non-cyclic pain for several months and maculopapular skin eruption in the same breast. Physical examination revealed fixed lymphadenopathies in both axillary regions. Radiologic evaluations (bilateral mammaograpy and ultrasonography) showed skin thickening in the left breast, asymmetrical densities in both breasts, and confirmed lymphadenopathies in the axillary regions. Excisional biopsies were performed to the left axillary lymph nodes and the breast skin eruptions. The histologic and immunohistochemical features were diagnosed as an ALK (−) anaplastic large cell lymphoma. A Computed Tomography examination was performed for staging the lymphoma and then chemotherapy was started. Thirty months after the diagnosis, the patient is still alive with disease. Because of the presence of systemic symptoms such as skin involvement and generalized lymphadenopathies (mediastinal, axillary or cervical), T cell lymphoma cases with breast involvement could mimic the clinical presentation of inflammatory breast carcinoma. Pathologic examination is needed for the correct diagnosis.
Literatur
1.
Zurück zum Zitat Domchek SM, Hecht JL, Fleming MD et al (2002) Lymphomas of the breast: primary and secondary involvement. Cancer 94(1):6–13PubMedCrossRef Domchek SM, Hecht JL, Fleming MD et al (2002) Lymphomas of the breast: primary and secondary involvement. Cancer 94(1):6–13PubMedCrossRef
3.
Zurück zum Zitat Kuper-Hommel MJ, Snijder S, Janssen-Heijnen ML et al (2003) Treatment and survival of 38 female breast lymphomas: a population-based study with clinical and pathological reviews. Ann Hematol 82(7):397–404. doi:10.1007/s00277-003-0664-7 PubMedCrossRef Kuper-Hommel MJ, Snijder S, Janssen-Heijnen ML et al (2003) Treatment and survival of 38 female breast lymphomas: a population-based study with clinical and pathological reviews. Ann Hematol 82(7):397–404. doi:10.​1007/​s00277-003-0664-7 PubMedCrossRef
5.
Zurück zum Zitat Topalovski M, Crisan D, Mattson JC (1999) Lymphoma of the breast. A clinicopathologic study of primary and secondary cases. Arch Pathol Lab Med 123(12):1208–1218PubMed Topalovski M, Crisan D, Mattson JC (1999) Lymphoma of the breast. A clinicopathologic study of primary and secondary cases. Arch Pathol Lab Med 123(12):1208–1218PubMed
7.
Zurück zum Zitat Fritzsche FR, Pahl S, Petersen I et al (2006) Anaplastic large-cell non-Hodgkin’s lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer, a case report. Virchows Arch 449(5):561–564. doi:10.1007/s00428-006-0287-1 PubMedCrossRef Fritzsche FR, Pahl S, Petersen I et al (2006) Anaplastic large-cell non-Hodgkin’s lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer, a case report. Virchows Arch 449(5):561–564. doi:10.​1007/​s00428-006-0287-1 PubMedCrossRef
11.
Zurück zum Zitat Press GA, Glazer HS, Wasserman TH et al (1985) Thoracic wall involvement by Hodgkin disease and non-Hodgkin lymphoma: CT evaluation. Radiology 157(1):195–198PubMed Press GA, Glazer HS, Wasserman TH et al (1985) Thoracic wall involvement by Hodgkin disease and non-Hodgkin lymphoma: CT evaluation. Radiology 157(1):195–198PubMed
13.
Zurück zum Zitat ten Berge RL, Oudejans JJ, Ossenkoppele GJ et al (2003) ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects, a review. J Pathol 200(1):4–15. doi:10.1002/path.1331 PubMedCrossRef ten Berge RL, Oudejans JJ, Ossenkoppele GJ et al (2003) ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects, a review. J Pathol 200(1):4–15. doi:10.​1002/​path.​1331 PubMedCrossRef
14.
Zurück zum Zitat ten Berge RL, Oudejans JJ, Ossenkoppele GJ et al (2000) ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination. J Clin Pathol 53(6):445–450. doi:10.1136/jcp.53.6.445 PubMedCrossRef ten Berge RL, Oudejans JJ, Ossenkoppele GJ et al (2000) ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination. J Clin Pathol 53(6):445–450. doi:10.​1136/​jcp.​53.​6.​445 PubMedCrossRef
15.
Zurück zum Zitat Escalón MP, Liu NS, Yang Y et al (2005) Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson cancer center experience. Cancer 103(10):2091–2098. doi:10.1002/cncr.20999 PubMedCrossRef Escalón MP, Liu NS, Yang Y et al (2005) Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson cancer center experience. Cancer 103(10):2091–2098. doi:10.​1002/​cncr.​20999 PubMedCrossRef
Metadaten
Titel
Secondary involvement of the breast in T-cell non-Hodgkin lymphoma, an unusual example mimicking inflammatory breast carcinoma
verfasst von
Canan Kelten
Sibel Kabukcu
Nilay Sen
Zafer Teke
Arzu Yaren
Ergun Erdem
Ender Duzcan
Publikationsdatum
01.07.2009
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2009
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-008-0869-z

Weitere Artikel der Ausgabe 1/2009

Archives of Gynecology and Obstetrics 1/2009 Zur Ausgabe

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.